vancomycin has been researched along with Critical Illness in 228 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (3.51) | 18.2507 |
| 2000's | 17 (7.46) | 29.6817 |
| 2010's | 126 (55.26) | 24.3611 |
| 2020's | 77 (33.77) | 2.80 |
| Authors | Studies |
|---|---|
| Khalili, H; Mohammadi, M; Mostafavi, Z; Rahmani, H; Salehi, M | 1 |
| Bang, JY; Choi, BM; Chong, YP; Hong, SK; Kang, HI; Lee, EK; Lee, HJ; Noh, GJ | 1 |
| Hayakawa, M; Imai, S; Mikami, R; Sugawara, M; Takekuma, Y | 1 |
| Akunne, OO; Argent, AC; Mugabo, P | 1 |
| Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS | 1 |
| Abdulla, A; de Winter, BCM; Endeman, H; Ewoldt, TMJ; Hunfeld, NGM; Koch, BCP; Muller, AE | 1 |
| Al Harbi, S; Al Sulaiman, K; Alghamdi, N; Alharbi, A; Alhelal, K; Aljuhani, O; Alsaeed, A; Alshaya, A; Alshehri, N; Althewaibi, S; Alzahrani, H; Vishwakarma, R | 1 |
| Briassoulis, G; Briassoulis, P | 1 |
| Coyle, M; D'Arcy, DM; Deasy, E; Donnelly, M; Judge, C; Kelly, YP; Kirwan, M; Lavin, PJ; Munshi, R; O'Keeffe, H | 1 |
| Abdelrahman, DH; AbuSara, AK; Al-Shaer, MH; Habash, KI; Le, J; Nazer, LH | 1 |
| Huang, GM; Liu, TT; Lu, JJ; Qiu, Y | 1 |
| Hohlfelder, B; Quinn, NJ; Sacha, GL; Srinivas, P; Wanek, MR; Yerke, J | 1 |
| Carlson, TJ; Garey, KW; Gonzales-Luna, AJ | 1 |
| Lizza, BD; Micek, ST; Raush, N | 1 |
| Beaubien Souligny, W; Cailhier, JF; Côté, JM; Desjardins, M; Murray, PT | 1 |
| Balamuth, F; Biedron, L; Chiotos, K; Dashefsky, H; Fitzgerald, JC; Gerber, JS; Hayes, M; Ku, BC; Metjian, TA; Robbins Tighe, S; Schriver, E; Stinson, H; Weiss, SL; Woods-Hill, C | 1 |
| Chung, KK; DeLuca, JP; Kress, AT; Reed, T; Selig, DJ; Stewart, IJ | 1 |
| Binyala, W; DeBacker, KC; Pai, MP; Pattharachayakul, S; Santimaleeworagun, W; Sitaruno, S; Vattanavanit, V | 1 |
| Al-Eyadhy, A; Al-Jelaify, MR | 1 |
| Hefny, F; Kung, JY; Mahmoud, SH; Morris, C; Sambhi, S; Stuart, A | 1 |
| Agyekum, RS; Anderson, BJ; Cosgriff, CV; Dunn, TG; Giannini, HM; Hennessy, S; Ittner, CAG; Jones, TK; Meyer, NJ; Miano, TA; Oniyide, O; Reilly, JP; Shashaty, MGS; Townsend, R; Turner, AP; Weisman, AR; Wilson, FP; Yang, W | 1 |
| Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC | 1 |
| Carr, AL; Hayes, J; Lopez-Ruiz, A; Louzon, PR; Marinucci, V; Sniffen, J | 1 |
| Liu, G; Qi, Y | 1 |
| Copelli, S; de Cal, M; de Rosa, S; Lorenzin, A; Marcello, M; Ronco, C; Sorbo, D; Zanella, M | 1 |
| Allegaert, K; Sürmelioğlu, N; Yalcin, N | 1 |
| Chai, MG; Cotta, MO; Farkas, A; Roberts, JA | 1 |
| Chen, J; Chen, L; Dong, Y; Li, S; Wang, C; Wang, T; Yang, B; Zhang, Y | 1 |
| Li, Z; Liu, H; Qi, B; Yuan, Y | 1 |
| Han, G; Liang, G; Liu, J; Yang, Y; Yu, H; Yu, L; Yu, Z; Zhao, Y; Zheng, Y; Zhong, L; Zhou, L; Zhu, J | 1 |
| Armengol de la Hoz, MÁ; Becker, CD; Calvachi-Prieto, P; Celi, LA; Chen, AY; Chen, C; Dagan, A; Deng, CY; Johnson, AEW; Khazi-Syed, A; Scurlock, C | 1 |
| Abdul Aziz, MH; Alshaer, MH; Ausman, SE; Barreto, EF; Boehmer, KR; Chitre, PN; Jannetto, PJ; Mara, KC; Moreland-Head, LN; Pine, KH; Rivera, CG; Roberts, JA; Rule, AD; Scheetz, MH; Shepel, KK | 1 |
| de Geus, HRH; Endeman, H; Hunfeld, NGM; Koch, BCP; Rietdijk, WJR; Rietveld, A; Smeets, TJL | 1 |
| Cotta, MO; Elhadi, M; Farkas, A; Imani, S; Kanji, S; Luque-Pardos, S; Roberts, JA; Sanches, C; Sandaradura, I; Scheetz, MH; Schellack, N; Tabah, A; Timsit, JF; Wilks, K; Williams, PG; Xie, J | 1 |
| Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Dubinsky, S; Grewal, A; Hiremath, S; Hutton, B; Kanji, S; Marko, R; Purkayastha, D; Thabet, P; Wong, K | 1 |
| Ayar, Y; Caliskan, G; Ceylan, İ; Kaya, PK; Kilic, I | 1 |
| Ghasemiyeh, P; Mohammadi-Samani, S; Vazin, A; Zand, F | 1 |
| Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF | 1 |
| Celii, A; Cross, A; Kennedy, R; Neely, S; Talledo, O; Villanueva, RD; White, B | 1 |
| Fuhrman, DY; Joyce, EL; Kane-Gill, SL; Kellum, JA; Priyanka, P | 1 |
| Melling, PA; Noto, MJ; Rice, TW; Semler, MW; Stollings, JL | 1 |
| Dao, XC; Delattre, IK; Do, HG; Ho, TT; Nguyen, DA; Nguyen, GB; Nguyen, HA; Pham, HN; Tran, NT; Tulkens, PM; Van Bambeke, F; Vu, DH | 1 |
| Avram, S; Dragic, S; Jovanovic, M; Kovacevic, P; Kovacevic, T; Miljkovic, B; Momcicevic, D; Vucicevic, K | 1 |
| Baptista, JP; Devesa, N; Freitas, R; Pimentel, J; Roberts, JA; Sousa, E | 1 |
| Campogiani, L; Eshwara, VK; Rello, J | 1 |
| Guan, X; Li, J; Ouyang, B; Shi, L; Wang, L; Wang, Y; Yao, M | 1 |
| Arnaud, FCS; Libório, AB | 1 |
| Kächele, M; Keller, F | 1 |
| Cavani Jorge Santos, SR; Chaves, L; Levin, AS; Macedo, E; Machado, AS; Mendes, ET; Oliveira, MS; Perdigão Neto, LV; Sanches, C; Vieira da Silva, C | 1 |
| Banoub, M; Blackman, AL; Claeys, KC; Heil, EL; Kristie Johnson, J; Leekha, S; Vega, AD | 1 |
| An, SH; Gwak, HS; Kim, JY; Lee, EM | 1 |
| Bastin, MT; Bissell, BD; Flannery, AH; Morris, PE; Neyra, JA | 1 |
| Brüggemann, R; de Jager, CPC; Derijks, HJ; Frenzel, T; Keizer, RJ; Smolders, EJ; Ter Heine, R; van Luin, M; van Steeg, K | 1 |
| De Bels, D; Honore, PM; Redant, S | 1 |
| Abe, K; Goto, T; Ito, K; Kamio, S; Saito, K; Suzuki, N | 1 |
| Allegaert, K; Flint, RB | 1 |
| de Hoop, M; de Wildt, SN; Hartman, SJF; Orriëns, LB; Poel, T; Zwaag, SM | 1 |
| Bian, X; Chen, E; He, J; Jing, F; Mao, E; Xu, W; Zhao, B | 1 |
| Cusumano, JA; Huttner, A; Klinker, KP; LaPlante, KL; Luther, MK; Roberts, JA | 1 |
| Hay, K; Marella, P; Roberts, J; Shekar, K | 1 |
| Bian, X; Chen, E; Gu, P; He, J; Li, J; Mao, E | 1 |
| Ko, WJ; Lin, SY; Shen, LJ; Wu, CC; Wu, FL; Wu, VC | 1 |
| Bress, J; Hite, MS; Rider, TR; Silinskie, KM | 1 |
| Grabein, B; Liebchen, U; Paal, M; Scharf, C; Schroeder, I; Siebers, C; Zander, J; Zoller, M | 1 |
| Downes, KJ; Zane, NR; Zuppa, AF | 1 |
| Anderson, DJ; Kram, BL; Kram, SJ; Kuhrt, MM; McRae, AS; Schultheis, JM | 1 |
| Ito, H | 1 |
| Banoub, M; Blackman, A; Claeys, KC; Heil, EL; Johnson, JK; Leekha, S; Vega, A | 1 |
| Burgess, DS; Cook, AM; Delozier, NL; Effoe, SA; Flannery, AH; Wallace, KL | 1 |
| Ajello, S; Calabrò, MG; Fominskiy, E; Melisurgo, G; Nardelli, P; Pappalardo, F; Pieri, M; Scandroglio, AM | 1 |
| Blair, M; Côté, JM; Cotter, A; Lynch, B; Murray, PT; Redahan, L | 1 |
| Gao, Y; Hou, Y; Jin, X; Li, J; Li, R; Ren, J; Wang, G; Wang, X; Zhang, J | 1 |
| Alffenaar, JW; Drennan, PG; Narayan, SW; Patanwala, AE; Thoma, Y; Van Hal, S; Yejin Kim, H | 1 |
| Almadrahi, Z; Cunmuljaj, L; Mouabbi, K; Wahby, KA; Wilpula, L | 1 |
| Abbasi, MY; Mulubwa, M; Sridharan, K | 1 |
| Berends, SE; de Jong, MD; Hakkens, N; Hodiamont, CJ; Juffermans, NP; Mathôt, RAA; van Hest, RM; van Vessem, DJ | 1 |
| Boukhris, MR; Décaudin, B; Gilliot, S; Le Duc, K; Masse, M; Odou, P; Storme, L | 1 |
| Daher, EF; Leite, TT; Parente Filho, SLA; Reis, ADF; Rocha, CVO; Silva Junior, GBD; Soares, DS | 1 |
| Bakke, V; Bugge, JF; Hårvig, KR; Helset, E; Lao, Y; Nordøy, I; Nyrerød, HC; Sandvik, L; Sporsem, H; Von der Lippe, E | 1 |
| Avedissian, SN; Bradley, E; Bradley, JS; Le, J; Nazer, LH; Nguyen, A; Tran, TM; Zhang, D | 1 |
| Barcia, E; Blasco-Navalpotro, MA; García, B; Medellín-Garibay, SE; Romano-Moreno, S; Rubio-Álvaro, N; Rueda-Naharro, A; Tejedor-Prado, P | 1 |
| Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ | 1 |
| Awdishu, L | 1 |
| de Moya, MA; Elshaboury, RH; Lin, H; Newman, K; Sin, JH; Yeh, DD | 1 |
| Chuma, M; Imai, T; Kikuchi, N; Kinoshita, K; Komatsu, T; Kuwana, T; Makishima, M; Sakaue, T; Sawada, N; Suzuki, S; Tochikura, N; Yoshida, Y | 1 |
| Imai, T | 1 |
| Beckman, EJ | 1 |
| Benaboud, S; Bouazza, N; Genuini, M; Lesage, F; Moulin, F; Oualha, M; Renolleau, S; Treluyer, JM | 1 |
| Bissell, BD; Morrison, C; Riggi, G | 1 |
| Wu, CC; Wu, CW; Yang, CJ | 1 |
| Choi, J; Leja, BM; Sargel, CL | 1 |
| Ackerman, KG; Bubeck Wardenburg, J; Cvijanovich, N; Gedeit, RG; Giuliano, JS; Hall, MW; Hartman, ME; Markovitz, B; Moffitt, KL; Newhams, MM; Novak, T; Randolph, AG; Sanders, RC; Shein, SL; Tarquinio, KM; Thomas, NJ; Truemper, EJ; Weiss, SL; Xu, R | 1 |
| Thomsen, IP | 1 |
| Fish, DN; Foster, CJ; Kassel, LE; Kiser, TH; MacLaren, R; Mueller, SW; Neumann, RT; Sherman, DS; Van Matre, ET; Wempe, MF | 1 |
| Cheong, HI; Choi, YH; Ha, IS; Jung, AH; Jung, SH; Kang, HG; Kim, SJ; Lee, B; Park, J; Park, JD | 1 |
| Forland, SC; Smith, SR; Truong, J; Veillette, JJ | 1 |
| Hewagama, S; Krishnaswamy, S; Lipman, J; Roberts, JA; Stewart, PC; Tsai, D; Wallis, SC | 1 |
| Keller, F | 1 |
| Krawczeski, CD; Kwiatkowski, DM; Montez-Rath, ME; Sutherland, SM; Uber, AM | 1 |
| Chan, D; Chang, E; Elbarbry, F; Kojiro, K; Turner, RB; Won, R | 1 |
| Jordan, JD; Morbitzer, KA; Nelson, NR; Rhoney, DH | 1 |
| Arikan, AA; Galati, M; Moffett, BS; Morris, J; Munoz, F | 1 |
| Deans, R; Lipman, J; Paul, SK; Roberts, JA; Samanta, M | 1 |
| Huang, M; Wu, H; Xu, M; Zhou, J; Zhou, S | 1 |
| Abraham, T; Chung, E; Gad, A; Lee, SE; Saad, NN | 1 |
| Fresco, P; Gonçalves, J; Hahn, SR; Monteiro, JF | 1 |
| Barreto, EF; Kashani, KB; Mara, KC; Nelson, S; Personett, HA; Rule, AD; Sakhuja, A; Schreier, DJ; Steckelberg, JM; Tande, AJ; Tootooni, MS | 1 |
| Harada, D; Kawakubo, T; Takinami, M; Uchino, S | 1 |
| Ge, QG; He, N; Yan, YY; Yao, GQ; Yi, M; Ying, YQ; Zhai, SD | 1 |
| Chan, D; Chang, E; Elbarbry, F; Kojiro, K; Shephard, EA; Turner, RB; Won, R | 1 |
| Janković, SM | 1 |
| Attou, R; De Bels, D; Gallerani, A; Honore, PM; Kugener, L; Redant, S; Spapen, HD | 1 |
| Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S | 1 |
| Hays, WB; Tillman, E | 1 |
| McLeay, RC | 1 |
| Elbarbry, F; Turner, RB | 1 |
| Chindavijak, B; Montakantikul, P; Setiawan, E; Suwannoi, L | 1 |
| Colson, P; Daures, JP; David, H; Eliet, J; Gaudard, P; Morquin, D; Saour, M; Villiet, M | 1 |
| Attou, R; De Bels, D; Gallerani, A; Honore, PM; Kashani, K; Redant, S | 1 |
| Andreolio, C; Antonacci Carvalho, PR; da Rocha, TS; Feiten, HDS; Martinbiancho, JK; Okumura, LM; Pedro Piva, J | 1 |
| Joyce, EL; Kane-Gill, SL; Kellum, JA; Ostermann, M; Shi, J | 1 |
| Juang, P; Kollef, MH; Micek, ST | 1 |
| Barreto, EF; Rule, AD; Schreier, DJ | 1 |
| Chiletti, R; Cranswick, N; Curtis, N; Gwee, A; Sosnin, N | 1 |
| Bourgeois, M; Danneels, I; De Waele, JJ; Decruyenaere, J; Depuydt, P; Hoste, E | 1 |
| Covajes, C; Jacobs, F; Lipman, J; Roberts, JA; Taccone, FS; Udy, AA; Vincent, JL | 1 |
| Arpino, PA; Golenia, BS; Levine, AR; Moawad, IM; Yeh, DD | 1 |
| Lee, H; Machado, J; Paredes, A; Raszynski, A; Totapally, BR | 1 |
| Denetclaw, TH; Dowling, TC; Steinke, D | 1 |
| Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
| Gramm, C; Huber, W; Lahmer, T; Meidert, AS; Messer, M; Saugel, B; Schmid, RM; Wagner, JY | 1 |
| Breden, A; Conil, JM; Cougot, P; Fourcade, O; Georges, B; Ruiz, S; Saivin, S | 1 |
| Jamal, JA; Lipman, J; Roberts, JA; Udy, AA | 1 |
| Andresen, M; Bórquez, T; Downey, P; Escobar, L; Gai, MN; Lipman, J; Regueira, T; Roberts, JA | 1 |
| Akova, M; Bassetti, M; Blot, S; De Waele, JJ; Dimopoulos, G; Kaukonen, KM; Koulenti, D; Lipman, J; Martin, C; Montravers, P; Rello, J; Rhodes, A; Roberts, JA; Starr, T; Wallis, SC | 1 |
| Chen, J; Chen, M; Guan, X; Jiang, Z; Lin, Z; Ouyang, B | 1 |
| Dulhunty, JM; Hanrahan, TP; Harlow, G; Hutchinson, J; Lipman, J; Roberts, JA; Whitehouse, T | 1 |
| Fagon, JY; Faisy, C; Mainardi, JL; Mangin, O; Urien, S | 1 |
| Chaijamorn, W; Wanakamanee, U | 1 |
| Drago, M; González, CA; Nalegach, ME; Vásquez, A; Villareal, M; Villena, R | 1 |
| Burdmann, EA; Costa e Silva, VT; Marçal, LJ | 1 |
| Belhaj, A; Beumier, M; Cristallini, S; de Backer, D; Donadello, K; Jacobs, F; Roberts, JA; Shekar, K; Taccone, FS; Vincent, JL | 1 |
| Cobian, J; Hall, AB; Montero, J; Regan, T | 1 |
| Baptista, JP; Deveza, N; Freitas, R; Pimentel, J; Roberts, JA; Sousa, E | 1 |
| Handler, SM; Kane-Gill, SL; Kellum, JA; Murugan, R; Sileanu, FE; Trietley, GS | 1 |
| Idemitsu, W; Igarashi, T; Imaura, M; Kanai, R; Kanno, H; Kohata, Y; Kohyama, T; Maki, Y; Takahashi, H; Yamada, Y; Yokoyama, H | 1 |
| Degnan, L; Meyers, R; Ringenberg, T; Robinson, C; Shah, P; Siu, A; Sturgill, M | 1 |
| Bachmeier, H; Flannery, AH | 1 |
| Dulhunty, JM; Hanrahan, TP; Harlow, G; Lipman, J; Roberts, JA; Whitehouse, T | 1 |
| Belhabib, G; Combes, A; Corvol, E; Farinotti, R; Fernandez, C; Fillâtre, P; Hasni, N; Lemaitre, F; Leprince, P; Leven, C; Luyt, CE | 1 |
| Beardsley, JR; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC | 1 |
| Berselli, A; Bertacchini, S; Capuzzo, M; Fogagnolo, A; Marangoni, E; Ragazzi, R; Spadaro, S; Volta, CA | 1 |
| Hsu, LF; Ko, WJ; Shen, LJ; Wu, CC; Wu, FL | 1 |
| Faine, B; Fuller, BM; Harland, KK; Mohr, N; Porter, B; Rolfes, K | 1 |
| Bouman, CS; Juffermans, NP; van Hest, RM; van Vessem, DJ | 1 |
| Hanrahan, TP; Kotapati, C; Lipman, J; Roberts, JA; Roberts, MJ; Rowland, J; Udy, A | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| Cho, YH; Chung, CR; In, YW; Jeon, K; Lee, YM; Park, CM; Park, HJ; Park, SJ; Suh, GY; Yang, JH | 1 |
| Araujo, OR; Arduini, RG; Petrilli, AS; Seixas, GT; Silva, DC | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| Gipmans, S; Petjak, M; van Maarseveen, EM; van Zanten, AR; Vasbinder, E | 1 |
| Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN | 1 |
| Elyasi, S; Khalili, H | 1 |
| Agrinier, N; Charmillon, A; Dellamonica, J; Demoré, B; Kimmoun, A; Leone, M; Levy, B; Novy, E; Pulcini, C | 1 |
| Hirai, K; Hirano, K; Ihara, S; Ikegaya, K; Itoh, K; Kinae, A; Suzuki, M | 1 |
| Beumier, M; Cotton, F; Creteur, J; Cristallini, S; Hites, M; Jacobs, F; Kabtouri, H; Lipman, J; Roberts, JA; Taccone, FS; Vincent, JL | 1 |
| Levine, AR; Lin, H; Yeh, DD | 1 |
| Hanrahan, TP; Lipman, J; Roberts, JA | 1 |
| Hirai, K; Inoue, K; Ishii, H; Itoh, K; Kadoiri, T; Shimomura, T; Shimoshikiryo, T; Tsuji, D | 1 |
| Eggimann, P; Paiva, JA | 1 |
| Gruneir, A; Howard, AW; Koren, G; Parshuram, CS; Rochon, PA; Slater, MB | 1 |
| Biarent, D; Colman, S; Commeyne, S; De Cock, PA; De Jaeger, A; De Paepe, P; Desmet, S; Dhont, E; Herck, I; Stove, V; Vande Walle, J; Vens, D | 1 |
| Eissing, T; Ellger, B; Hempel, G; Horn, D; Lanckohr, C; Meyer, M; Radke, C | 1 |
| Barreto, JN; Dierkhising, RA; Frazee, E; Kashani, KB; Kuper, PJ; Leung, N; Lieske, JC; Rule, AD; Virk, A | 1 |
| Bedos, JP; Bruneel, F; Caille, V; Eurin, M; Grimaldi, D; Lacave, G; Legriel, S; Palette, C | 1 |
| Crapis, M; Cristini, F; Furlanut, M; Negri, C; Pavan, F; Pea, F; Viale, P | 1 |
| Lee, H; Norozian, F; Raszynski, A; Torbati, D; Totapally, BR; Valcourt, K | 1 |
| Hutschala, D; Kinstner, C; Müller, M; Skhirdladze, K; Thalhammer, F; Tschernko, E | 1 |
| Erstad, BL; Kopp, BJ; Nix, DE; Norris, CJ; Patanwala, AE | 1 |
| Schlaudecker, JD | 1 |
| Aubert, G; Auboyer, C; Carricajo, A; Forgeot, A; Morel, J; Zeni, F | 1 |
| Furlanut, M; Pea, F; Viale, P | 1 |
| Bonet, A; de Batlle, J; de la Torre, M; Motjé, M; Piñeiro, L; Sirvent, JM | 1 |
| Furuta, N; Ieiri, I; Imanishi, Y; Ito, H; Itoh, Y; Nakano, S; Niwa, T; Ogura, S; Ohmori, T; Seishima, M; Shirai, K; Suzuki, A; Takemura, M; Yoshida, S | 1 |
| Giachetto, GA; Menchaca, A; Nanni, L; Oyarzun, M; Speranza, N; Telechea, HM | 1 |
| Jeurissen, A; Rutsaert, R; Sluyts, I | 1 |
| Álvarez Lerma, F; García Simón, M; González Pérez, MI; Rodriguez Colomo, O; Sirvent, JM | 1 |
| Jacobs, F; Lipman, J; Roberts, JA; Taccone, FS; Udy, AA; Vincent, JL | 1 |
| Amaya-Villar, R; de la Torre, MV; Garnacho-Montero, J; Gómez-Grande, ML; Jerez, V; Lorente-Ramos, L; Loza, A; Martínez, A; Ortiz, C; Pomares, J; Pozo, JC; Sierra, R | 1 |
| Hilpert, JW; Kees, MG; Vögeler, S | 1 |
| Chaijamorn, W; Dandecha, P; Jitsurong, A; Wanakamanee, U; Wiwattanawongsa, K | 1 |
| Aubron, C; Cheng, AC; Corallo, CE; Dooley, MJ; Nunn, MO | 1 |
| Fujita, T; Hanafusa, N; Hisaka, A; Katada, S; Noiri, E; Suzuki, H; Yahagi, N; Yamamoto, T; Yasuno, N | 1 |
| Kirkpatrick, CM; Li, J; Lipman, J; Roberts, JA; Udy, AA | 1 |
| Lipman, J; Roberts, JA; Udy, AA | 1 |
| Cho, EM; Chung, J; Hong, SB; Jang, HJ; Koh, YS; Lim, CM; Oh, JM | 1 |
| Levkovich, BJ; Padiglione, AA; Truong, J | 1 |
| Baptista, JP; Martins, PJ; Pimentel, JM; Sousa, E | 1 |
| Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
| Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS | 1 |
| Boucher, BA; Christopher Wood, G; Croce, MA; Fabian, TC; Hamilton, LA; Magnotti, LJ; Martin, JB; Swanson, JM | 1 |
| Abdul Rahman, R; Cheong, JY; Lau, CL; Makmor-Bakry, M | 1 |
| Duricová, J; Grundmann, M; Kacířová, I; Martínek, A; Petejová, N; Plášek, J; Valkovský, I; Zahálková, J | 1 |
| Matejovic, M; Radej, J | 1 |
| Imaura, M; Kohata, Y; Kohyama, T; Nagafuchi, H; Takahashi, H; Yamada, Y; Yokoyama, H | 1 |
| Brozmannova, H; Duricova, J; Grundmann, M; Kacirova, I; Martinek, A; Petejova, N; Plasek, J; Urbanek, K; Zahalkova, J | 1 |
| Chowdhury, A; Patel, VM; Shorr, AF; Woods, CJ | 1 |
| Bertolissi, M; Di Silvestre, A; Furlanut, M; Giordano, F; Pea, F; Poz, D | 1 |
| Auckenthaler, R; Garbino, J; Hugonnet, S; Lew, DP; Pittet, D; Romand, JA | 1 |
| Bellomo, R; Cole, L; Goldsmith, D; Morimatsu, H; Uchino, S | 1 |
| Alcalá, MA; Alvarez Lerma, F; Blanco, A; Insausti, J; Olaechea, P; Palomar, M | 1 |
| DelDot, ME; Lipman, J; Tett, SE | 1 |
| Alex, CP; Garland, JS; Henrickson, KJ; Maki, DG; McAuliffe, TL | 1 |
| Argaud, L; Descloux, E; Le Scanff, J; Mohammedi, I; Robert, D | 1 |
| Bergamasco, S; Donadio, C; Malacarne, P | 1 |
| Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C | 1 |
| Aarts, MA; Bohnen, JM; Cook, DJ; Granton, J; Marshall, JC | 1 |
| Gerónimo-Pardo, M | 1 |
| Anandan, JV; Dumler, F; Patel, RV; Touchette, MA; Zarowitz, BJ | 1 |
| Beaucaire, G; Beuscart, C; Georges, H; Guery, B; Leroy, O; Santré, C; Simon, M | 1 |
| Alexander, F; Grundfest-Broniatowski, S; Lavery, I; Milsom, J; Quader, M; Walsh, RM | 1 |
| Dance, MD; Gous, AG; Lipman, J; Luyt, DK; Mathivha, R; Scribante, J | 1 |
| Ang, B; Balram, C; Lee, EJ; Lim, BL; Wong, SY | 1 |
| Alfandari, S; Beaucaire, G; Dhennain, C; Georges, H; Guery, B; Leroy, O; Roussel-Delvallez, M | 1 |
| Blankestijn, PJ; Boereboom, FT; Savelkoul, TJ; van Dijk, A; Ververs, FF | 1 |
| Baraibar, J; Barcenilla, F; Bodi, M; Castander, D; Correa, H; Diaz, E; Garnacho, J; Llorio, M; Paiva, JA; Rello, J; Rios, M; Rodriguez, A; Solé-Violán, J | 1 |
| Ackerman, BH; Vannier, AM | 1 |
19 review(s) available for vancomycin and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Infant, Newborn; Male; Vancomycin | 2022 |
Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Vancomycin | 2022 |
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Critical Illness; Fecal Microbiota Transplantation; Humans; Vancomycin | 2022 |
Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Critical Illness; Humans; Intensive Care Units; Vancomycin | 2022 |
Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Infant; Infant, Newborn; Midazolam; Morphine; Vancomycin | 2022 |
Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Critical Illness; Humans; Intermittent Renal Replacement Therapy; Renal Replacement Therapy; Vancomycin | 2023 |
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult | 2020 |
[Pharmacokinetics and pharmacodynamics in extracorporeal renal replacement therapy].
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Meropenem; Piperacillin; Renal Dialysis; Renal Replacement Therapy; Vancomycin | 2021 |
Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Humans; Infusions, Intravenous; Observational Studies as Topic; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Humans; Obesity; Precision Medicine; Vancomycin | 2020 |
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antimicrobial Stewardship; Creatinine; Critical Illness; Drug Therapy, Combination; Humans; Kidney Tubules; Nephritis; Patient Acuity; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2021 |
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies.
Topics: Acute Kidney Injury; Critical Illness; Disease Susceptibility; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Renal Replacement Therapy; Risk Factors; Vancomycin | 2017 |
[Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion].
Topics: Critical Care; Critical Illness; Drug Monitoring; Drug Therapy; Emergency Medical Services; Humans; Phenytoin; Systemic Inflammatory Response Syndrome; Vancomycin | 2017 |
[Pharmacotherapy and kidney dysfunction].
Topics: Anti-Bacterial Agents; Critical Illness; Glomerular Filtration Rate; Humans; Kidney Diseases; Meropenem; Pharmacokinetics; Piperacillin; Vancomycin | 2019 |
Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Nomograms; Renal Dialysis; Vancomycin | 2016 |
[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin; Vancomycin Resistance | 2011 |
[An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Clostridium difficile colitis in the critically ill.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Colectomy; Combined Modality Therapy; Critical Illness; Enterocolitis, Pseudomembranous; Female; Hospital Mortality; Humans; Male; Metronidazole; Middle Aged; Morbidity; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia.
Topics: Anti-Bacterial Agents; Bronchoscopy; Critical Illness; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia; Practice Guidelines as Topic; Respiration, Artificial; Streptococcus pneumoniae; Time Factors; Vancomycin | 2001 |
13 trial(s) available for vancomycin and Critical Illness
| Article | Year |
|---|---|
Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Critical Illness; Female; Humans; Incidence; Length of Stay; Logistic Models; Magnesium Sulfate; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2021 |
Time to First Culture Positivity Among Critically Ill Adults With Methicillin-Resistant
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cohort Studies; Critical Illness; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Sputum; Staphylococcal Infections; Vancomycin | 2020 |
A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients.
Topics: Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin | 2018 |
Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Humans; Linear Models; Male; Middle Aged; Prospective Studies; Taiwan; Vancomycin; Young Adult | 2016 |
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Critical Illness; Cystatin C; Drug Dosage Calculations; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Prospective Studies; Quality Improvement; Vancomycin | 2017 |
Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Vancomycin | 2010 |
Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Hospitals, University; Humans; Intensive Care Units; Male; Medical Audit; Middle Aged; Postoperative Complications; Practice Guidelines as Topic; Quality Improvement; Standard of Care; Staphylococcal Infections; Vancomycin; Victoria | 2012 |
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Vancomycin | 2002 |
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Chi-Square Distribution; Critical Illness; Decontamination; Digestive System; Double-Blind Method; Female; Fluconazole; Humans; Intensive Care Units; Male; Neomycin; Polymyxins; Prospective Studies; Risk Factors; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vancomycin | 2002 |
A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Critical Illness; Cross Infection; Double-Blind Method; Heparin; Humans; Hypoglycemia; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2005 |
Validity of Bayesian forecasting programme in therapeutic drug monitoring of vancomycin in a surgical intensive care unit: a prospective evaluation.
Topics: Aged; Bayes Theorem; Critical Illness; Drug Monitoring; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Prospective Studies; Regression Analysis; Singapore; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1996 |
Pulmonary disposition of vancomycin in critically ill patients.
Topics: Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Critical Illness; Female; Humans; Injections, Intravenous; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1997 |
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Topics: Acrylic Resins; Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hemofiltration; Humans; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure; Shock, Septic; Time Factors; Vancomycin | 1999 |
196 other study(ies) available for vancomycin and Critical Illness
| Article | Year |
|---|---|
Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients.
Topics: Aged; Anti-Bacterial Agents; Computer Simulation; Critical Illness; Humans; Prospective Studies; Vancomycin | 2022 |
Clinical applicability of urinary creatinine clearance for determining the initial dose of vancomycin in critically ill patients.
Topics: Anti-Bacterial Agents; Creatinine; Critical Illness; Humans; Kidney; Renal Insufficiency; Vancomycin | 2022 |
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin | 2022 |
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin | 2021 |
Bayesian Models for Therapeutic Monitoring of Vancomycin in the Critically Ill: What Should They Predict?
Topics: Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Drug Monitoring; Humans; Vancomycin | 2022 |
Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
Topics: Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Critical Illness; Hemodiafiltration; Humans; Renal Dialysis; Retrospective Studies; Vancomycin | 2021 |
Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cohort Studies; Critical Illness; Drug Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin | 2022 |
Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study.
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Infant; Kidney; Retrospective Studies; Vancomycin | 2022 |
Determinants of Vancomycin Trough Concentration in Patients Receiving Continuous Veno-Venous Hemodialysis.
Topics: Adult; Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Critical Illness; Dialysis Solutions; Humans; Retrospective Studies; Vancomycin | 2022 |
Antibiotic Optimization in the Intensive Care Unit.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pseudomonas; Retrospective Studies; Vancomycin | 2022 |
Improving Vancomycin Stewardship in Critically Ill Children.
Topics: Anti-Bacterial Agents; Child; Critical Illness; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
Topics: Anti-Bacterial Agents; Critical Illness; Gentamicins; Hemoperfusion; Humans; Imipenem; Meropenem; Vancomycin | 2023 |
Comparison of Race-Based and Non-Race-Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing.
Topics: Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Humans; Kidney; Male; Thailand; Vancomycin | 2022 |
Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome.
Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Anti-Bacterial Agents; Child; Critical Illness; Humans; Retrospective Studies; Vancomycin | 2022 |
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biomarkers; Cefepime; Creatinine; Critical Illness; Cystatin C; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Renal Dialysis; Retrospective Studies; Vancomycin | 2022 |
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin | 2023 |
Pharmacist-Driven Methicillin-Resistant
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Pharmacists; Pneumonia, Staphylococcal; Polymerase Chain Reaction; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2023 |
A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Critical Illness; Drug Monitoring; Humans; Imipenem; Linezolid; Meropenem; Micafungin; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Tigecycline; Vancomycin; Voriconazole | 2022 |
Vancomycin Adsorption during in vitro Model of Hemoperfusion with Mini-Module of HA380 Cartridge.
Topics: Adsorption; Anti-Bacterial Agents; Critical Illness; Hemoperfusion; Humans; Vancomycin | 2023 |
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Humans; Meropenem; Piperacillin; Sepsis; Software; Vancomycin | 2023 |
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.
Topics: Adult; Anti-Bacterial Agents; Bayes Theorem; Continuous Renal Replacement Therapy; Critical Illness; Humans; Renal Replacement Therapy; Retrospective Studies; Vancomycin | 2023 |
Vancomycin below the standard level of blood concentration to treat a critically ill child.
Topics: Anti-Bacterial Agents; Child; Critical Illness; Humans; Vancomycin | 2023 |
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Critical Illness; Drug Monitoring; Humans; Microbial Sensitivity Tests; Renal Dialysis; Retrospective Studies; Vancomycin | 2023 |
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Vancomycin | 2023 |
Pursuing the Real Vancomycin Clearance during Continuous Renal Replacement Therapy in Intensive Care Unit Patients: Is There Adequate Target Attainment?
Topics: Adult; Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Critical Care; Critical Illness; Humans; Intensive Care Units; Renal Replacement Therapy; Vancomycin | 2023 |
International survey of antibiotic dosing and monitoring in adult intensive care units.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Vancomycin | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |
Nephrotoxicity caused by colistin use in ICU: a single centre experience.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin | 2023 |
Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Female; Guideline Adherence; Humans; Infusions, Intravenous; Injury Severity Score; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Staphylococcal Infections; Vancomycin; Wounds and Injuries | 2019 |
Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2019 |
Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Topics: Adult; Aged; Anti-Bacterial Agents; Computer Simulation; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Enterococcus; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Staphylococcus aureus; Vancomycin | 2019 |
Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies; Sepsis; Vancomycin; Young Adult | 2020 |
Attainment of therapeutic vancomycin level within the first 24 h: Authors' response.
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Methicillin-Resistant Staphylococcus aureus; Nomograms; Vancomycin | 2019 |
Understanding resistance in enterococcal infections.
Topics: Anti-Bacterial Agents; Bacteremia; Critical Illness; Daptomycin; Drug Resistance, Multiple; Endocarditis; Enterococcus faecium; Humans; Intraabdominal Infections; Linezolid; Microbial Sensitivity Tests; Tigecycline; Vancomycin | 2020 |
[Analysis of influencing factors of trough serum vancomycin concentrations in critically ill neurosurgical patients].
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Vancomycin | 2019 |
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Models, Structural; Retrospective Studies; Vancomycin | 2020 |
Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency Dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Hybrid Renal Replacement Therapy; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Young Adult | 2020 |
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; APACHE; Clostridium Infections; Cohort Studies; Critical Illness; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Male; Retrospective Studies; Vancomycin | 2020 |
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Critical Illness; Female; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Vancomycin; Young Adult | 2020 |
Continuous Versus Intermittent Infusion of Vancomycin: Toward the End of the Controversy or Even Closer to the Swan Song?
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Vancomycin | 2020 |
A simple scoring method to predict augmented renal clearance in haematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Critical Illness; Female; Hematologic Neoplasms; Humans; Japan; Kidney Function Tests; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Vancomycin | 2020 |
Target Drug Exposure Attainment in Children: How to Get from Better to Best.
Topics: Anti-Bacterial Agents; Child; Critical Illness; Gentamicins; Humans; Infant, Newborn; Tobramycin; Vancomycin | 2020 |
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Gentamicins; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Retrospective Studies; Tobramycin; Vancomycin | 2020 |
[High dose vitamin C significantly reduces the nephrotoxicity of vancomycin in critically ill patients].
Topics: Acute Disease; Ascorbic Acid; China; Critical Illness; Humans; Neurotoxicity Syndromes; Pancreatitis; Retrospective Studies; Vancomycin | 2020 |
Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.
Topics: Adult; Critical Illness; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Renal Replacement Therapy; Vancomycin | 2020 |
[Protective effects of reduced glutathione on renal toxicity induced by vancomycin in critically ill patients].
Topics: Acute Disease; Anti-Bacterial Agents; China; Critical Illness; Glutathione; Humans; Intensive Care Units; Kidney; Pancreatitis; Prognosis; Retrospective Studies; Vancomycin | 2020 |
Pharmacokinetics and dosing of vancomycin in patients undergoing sustained low efficiency daily diafiltration (SLEDD-f): A prospective study.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Critical Illness; Humans; Hybrid Renal Replacement Therapy; Prospective Studies; Vancomycin | 2021 |
Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Middle Aged; Renal Dialysis; Vancomycin | 2020 |
The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Cross-Sectional Studies; Drug Monitoring; Germany; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Physicians; Piperacillin; Surveys and Questionnaires; Treatment Outcome; Vancomycin | 2020 |
Effect of Cystatin C on Vancomycin Clearance Estimation in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach.
Topics: Biomarkers; Child; Creatinine; Critical Illness; Cystatin C; Female; Glomerular Filtration Rate; Humans; Male; Vancomycin | 2020 |
VanA rectal swab screening as a predictor of subsequent vancomycin-resistant enterococcal bloodstream infection in critically ill adults.
Topics: Adult; Bacteremia; Bacterial Proteins; Critical Illness; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".
Topics: Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin | 2020 |
Reply to Letters to the Editor.
Topics: Anti-Infective Agents; Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin | 2020 |
First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Topics: Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kentucky; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Tertiary Care Centers; Vancomycin | 2020 |
Impact of CytoSorb on kinetics of vancomycin and bivalirudin in critically ill patients.
Topics: Anti-Bacterial Agents; Antithrombins; Biomarkers; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Hemadsorption; Hirudins; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Peptide Fragments; Recombinant Proteins; Retrospective Studies; Vancomycin | 2021 |
An evaluation on the association of vancomycin trough concentration with mortality in critically ill patients: A multicenter retrospective study.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cohort Studies; Critical Illness; Drug Monitoring; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; ROC Curve; Vancomycin | 2021 |
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration.
Topics: Adult; Continuous Renal Replacement Therapy; Critical Illness; Dose-Response Relationship, Drug; Humans; Retrospective Studies; Vancomycin | 2021 |
Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Models, Biological; Monte Carlo Method; Retrospective Studies; Tissue Distribution; Vancomycin | 2021 |
Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Incidence; Retrospective Studies; Vancomycin | 2021 |
Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Topics: Adult; Critical Illness; Endothelial Cells; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Necrosis; Vancomycin | 2021 |
Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Brazil; Critical Illness; Cross-Sectional Studies; Female; Humans; Incidence; Male; Middle Aged; Polymyxin B; Risk Factors; Vancomycin | 2017 |
Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
Topics: Adult; Anti-Bacterial Agents; Creatinine; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Microbial; Female; Guidelines as Topic; Humans; Male; Middle Aged; Norway; Prospective Studies; Renal Replacement Therapy; Vancomycin | 2017 |
Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Biomarkers; Child; Child, Preschool; Creatinine; Critical Care; Critical Illness; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Infant; Linear Models; Male; Metabolic Clearance Rate; Models, Theoretical; Retrospective Studies; Vancomycin; Young Adult | 2017 |
Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Creatinine; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Nomograms; Respiration, Artificial; Vancomycin | 2017 |
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Topics: Anti-Bacterial Agents; Critical Illness; Gram-Positive Bacterial Infections; Hemofiltration; Humans; Metabolic Clearance Rate; Nomograms; Prospective Studies; Renal Insufficiency; Tertiary Care Centers; Vancomycin | 2018 |
Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin | 2018 |
Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up?
Topics: Acute Kidney Injury; Child; Critical Illness; Humans; Piperacillin; Tazobactam; Vancomycin | 2017 |
Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Critical Illness; Female; France; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Pediatric; Male; Retrospective Studies; Vancomycin | 2018 |
Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
Topics: Adult; Anti-Bacterial Agents; Critical Care Outcomes; Critical Illness; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin; Wounds and Injuries | 2020 |
Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Hemofiltration; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 2018 |
Vancomycin Dosing: One Size Does Not Fit All.
Topics: Anti-Bacterial Agents; Child; Critical Illness; Humans; Vancomycin | 2018 |
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Coinfection; Critical Illness; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2019 |
The Concern for Vancomycin Failure in the Treatment of Pediatric Staphylococcus aureus Disease.
Topics: Child; Coinfection; Critical Illness; Humans; Influenza, Human; Methicillin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Female; Hemodiafiltration; Humans; Infant; Male; Metabolic Clearance Rate; Oliguria; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Vancomycin | 2018 |
Optimised dosing of vancomycin in critically ill Indigenous Australian patients with severe sepsis.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Population Groups; Prospective Studies; Sepsis; Vancomycin | 2018 |
Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
Topics: Acute Kidney Injury; Adolescent; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Critical Illness; Enalapril; Female; Heart Defects, Congenital; Humans; Ibuprofen; Infant; Ketorolac; Male; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Vancomycin | 2018 |
Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Humans; Male; Middle Aged; Poland; Population Surveillance; Vancomycin; Young Adult | 2018 |
The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Topics: Adult; Anti-Bacterial Agents; Brain Injuries, Traumatic; Creatinine; Critical Illness; Female; Humans; Infections; Male; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2019 |
Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Extracorporeal Membrane Oxygenation; Female; Humans; Infant; Infant, Newborn; Male; Metabolic Clearance Rate; Retrospective Studies; Vancomycin | 2018 |
A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Middle Aged; Models, Biological; Models, Statistical; Regression Analysis; Renal Replacement Therapy; Vancomycin | 2019 |
Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
Topics: Aged, 80 and over; Anti-Bacterial Agents; APACHE; China; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Kidney Diseases; Logistic Models; Male; Multivariate Analysis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Vancomycin | 2018 |
Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
Topics: Administration, Intravenous; Algorithms; Anti-Bacterial Agents; Clinical Protocols; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies; Vancomycin | 2019 |
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations.
Topics: Aged; Anti-Bacterial Agents; Burns; Child; Critical Illness; Drug Monitoring; Hematologic Diseases; Humans; Infant, Newborn; Models, Biological; Neurosurgical Procedures; Obesity; Renal Insufficiency; Vancomycin | 2018 |
Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Female; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Pseudomonas Infections; Severity of Illness Index; Vancomycin | 2019 |
Predictability of serum vancomycin concentrations using the kinetic estimated glomerular filtration rate formula for critically ill patients
.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Models, Biological; Predictive Value of Tests; Renal Elimination; Reproducibility of Results; Retrospective Studies; Vancomycin | 2018 |
[Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Hemofiltration; Humans; Pancreatitis; Vancomycin | 2018 |
Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.
Topics: Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Male; Prospective Studies; Reproducibility of Results; Software; Vancomycin | 2018 |
Clinical Application of Pharmacokinetics: Basis for Rational Dose Selection in a Critically Ill Patient on Renal Replacement Therapy.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Meropenem; Metabolic Clearance Rate; Renal Dialysis; Sepsis; Time Factors; Treatment Outcome; Vancomycin | 2019 |
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Obesity; Vancomycin | 2019 |
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin | 2019 |
Vancomycin-Associated Acute Kidney Injury in Critically Ill Adolescent and Young Adult Patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin; Young Adult | 2020 |
Critique of Vancomycin Dose-Optimizing Software Review.
Topics: Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Humans; Software; Vancomycin | 2019 |
Dr. Turner Responds to Dr. McLeay.
Topics: Bayes Theorem; Critical Illness; Humans; Software; Vancomycin | 2019 |
Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon.
Topics: Anti-Bacterial Agents; Computer Simulation; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Staphylococcal Infections; Thailand; Vancomycin | 2019 |
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Critical Illness; Daptomycin; Endocarditis; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Odds Ratio; Propensity Score; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2019 |
Attainment of therapeutic vancomycin level within the first 24 h.
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Methicillin-Resistant Staphylococcus aureus; Nomograms; Vancomycin | 2019 |
Vancomycin-associated Nephrotoxicity and Risk Factors in Critically Ill Children Without Preexisting Renal Injury.
Topics: Acute Disease; Acute Kidney Injury; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Electronic Health Records; Female; Humans; Infant; Intensive Care Units, Pediatric; Kidney; Male; Models, Statistical; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.
Topics: Anti-Bacterial Agents; Biomarkers; Critical Illness; Drug Therapy, Combination; Humans; Kidney Diseases; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2019 |
Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Reply to Kollef et al.
Topics: Acute Kidney Injury; beta-Lactams; Critical Illness; Humans; Incidence; Vancomycin | 2020 |
Vancomycin is commonly under-dosed in critically ill children and neonates.
Topics: Administration, Intravenous; Adolescent; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Kidney Diseases; Male; Medical Records; Retrospective Studies; Sepsis; Vancomycin | 2019 |
Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Serum; Vancomycin | 2013 |
Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Replacement Therapy; Sepsis; Vancomycin | 2013 |
Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients.
Topics: Anti-Bacterial Agents; Body Weight; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Nomograms; Prospective Studies; Retrospective Studies; Vancomycin | 2013 |
Acute kidney injury during vancomycin therapy in critically ill children.
Topics: Acute Kidney Injury; Adolescent; Analysis of Variance; Anti-Bacterial Agents; Blood Urea Nitrogen; Child; Child, Preschool; Cohort Studies; Critical Illness; Female; Glomerular Filtration Rate; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Retrospective Studies; Risk Factors; Time Factors; Vancomycin | 2013 |
Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Vancomycin | 2013 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: an observational study in intensive care unit patients.
Topics: Aged; Algorithms; Anti-Bacterial Agents; Clinical Protocols; Critical Illness; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Vancomycin | 2014 |
Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?
Topics: Adult; Aged; Anti-Bacterial Agents; Cooperative Behavior; Critical Illness; Female; Glomerular Filtration Rate; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Vancomycin | 2014 |
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Piperacillin; Renal Replacement Therapy; Thienamycins; Vancomycin | 2014 |
Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, Liquid; Critical Illness; Female; Hemofiltration; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Plasma; Prospective Studies; Shock, Septic; Tandem Mass Spectrometry; Vancomycin; Young Adult | 2014 |
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Internationality; Male; Middle Aged; Prospective Studies; Vancomycin | 2014 |
[Clinical research for trough value of serum vancomycin in critical patients].
Topics: Adult; Aged; Aged, 80 and over; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Vancomycin | 2014 |
Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Organ Dysfunction Scores; Prevalence; Regression Analysis; Retrospective Studies; Vancomycin | 2014 |
Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Critical Illness; Female; Humans; Male; Mediastinitis; Middle Aged; Models, Biological; Postoperative Complications; Sternotomy; Vancomycin | 2014 |
Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Dialysis Solutions; Female; Humans; Immunoassay; Male; Middle Aged; Plasma; Prospective Studies; Renal Dialysis; Vancomycin; Young Adult | 2014 |
[Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infant; Infusions, Intravenous; Intensive Care Units, Pediatric; Male; Retrospective Studies; Vancomycin | 2014 |
Risk factors for vancomycin nephrotoxicity: still a matter of debate*.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2014 |
Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2014 |
The effects of an electronic order set on vancomycin dosing in the ED.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Emergency Service, Hospital; Female; Humans; Male; Medical Order Entry Systems; Medication Errors; Middle Aged; Retrospective Studies; Vancomycin | 2015 |
Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nomograms; Retrospective Studies; Time Factors; Vancomycin | 2014 |
Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cohort Studies; Comorbidity; Critical Illness; Female; Humans; Hypertension; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; ROC Curve; Sepsis; Vancomycin; Young Adult | 2015 |
Initial dosing regimen of vancomycin to achieve early therapeutic plasma concentration in critically ill patients with MRSA infection based on APACHE II score.
Topics: Adult; Aged; APACHE; Bayes Theorem; Critical Illness; Female; Half-Life; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2016 |
Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Critical Illness; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Serum; Staphylococcal Infections; Vancomycin | 2015 |
Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
The authors reply.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.
Topics: Anti-Infective Agents; Blood; Critical Illness; Cyclosporine; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Hypnotics and Sedatives; Midazolam; Models, Biological; Polyvinyl Chloride; Propofol; Vancomycin | 2015 |
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Critical Illness; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2015 |
Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Drug Dosage Calculations; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sepsis; Vancomycin | 2015 |
Importance of Decision Support Implementation in Emergency Department Vancomycin Dosing.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Decision Support Systems, Clinical; Electronic Health Records; Emergency Service, Hospital; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Medication Errors; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2015 |
The Area Under the Concentration-Time Curve Is a Better Estimate for Vancomycin Exposure Than Trough Levels.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
Factors associated with vancomycin nephrotoxicity in the critically ill.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; APACHE; Critical Illness; Female; Humans; Logistic Models; Male; Middle Aged; Vancomycin | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Tissue Distribution; Vancomycin | 2015 |
Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Kidney; Male; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2016 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Cohort Studies; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Vancomycin | 2016 |
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Topics: Adult; Aged; Anti-Bacterial Agents; Attitude of Health Personnel; beta-Lactams; Critical Illness; Cross-Sectional Studies; Drug Monitoring; Drug Utilization; Female; France; Humans; Male; Middle Aged; Professional Competence; Surveys and Questionnaires; Vancomycin | 2016 |
Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Asian People; Bayes Theorem; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Infant; Logistic Models; Male; Multivariate Analysis; Risk Factors; Vancomycin | 2016 |
New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Sepsis; Vancomycin | 2016 |
Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Attention; Body Mass Index; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Obesity; Retrospective Studies; Vancomycin | 2016 |
Antibiotic dosing in obesity: a BIG challenge.
Topics: Anti-Bacterial Agents; Critical Illness; Humans; Infections; Obesity; Vancomycin | 2016 |
Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Febrile Neutropenia; Female; Humans; Kidney; Kidney Function Tests; Logistic Models; Male; Middle Aged; Risk Factors; Vancomycin | 2016 |
Treatment of severe MRSA infections: current practice and further development.
Topics: Anti-Bacterial Agents; Critical Illness; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2017 |
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Topics: Acute Kidney Injury; Adolescent; Case-Control Studies; Child; Child, Preschool; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Furosemide; Gentamicins; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?
Topics: Adolescent; Anti-Bacterial Agents; Blood Proteins; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Linear Models; Male; Microbial Sensitivity Tests; Prospective Studies; Protein Binding; Vancomycin | 2017 |
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Proteins; Critical Illness; Cytochrome P-450 Enzyme System; Female; Hematocrit; Humans; Kidney; Liver; Male; Middle Aged; Models, Biological; Sepsis; Vancomycin; Young Adult | 2017 |
Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Critical Illness; Female; France; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nomograms; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Drug use density in critically ill children and newborns: analysis of various methodologies.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Utilization Review; Humans; Infant; Intensive Care Units, Pediatric; Intensive Care, Neonatal; Linezolid; Oxazolidinones; Retrospective Studies; Vancomycin | 2009 |
Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Cardiac Surgical Procedures; Creatinine; Critical Care; Critical Illness; Cross Infection; Female; Hemofiltration; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Vancomycin; Young Adult | 2009 |
Vancomycin dosing for pneumonia in critically ill trauma patients.
Topics: Adult; Anti-Bacterial Agents; Comorbidity; Critical Illness; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Vancomycin; Wounds and Injuries | 2009 |
A refractory case of community-acquired pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
[Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
Topics: Anti-Bacterial Agents; Clinical Protocols; Critical Care; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Monitoring; Hospitals, University; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Recovery Room; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vancomycin | 2010 |
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?
Topics: Anti-Bacterial Agents; Biological Availability; Creatinine; Critical Illness; Humans; Pneumonia, Bacterial; Renal Insufficiency; Vancomycin; Wounds and Injuries | 2010 |
Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Creatinine; Critical Illness; Cystatin C; Drug Administration Schedule; Female; Humans; Kidney; Male; Middle Aged; Models, Biological; Reproducibility of Results; Vancomycin; Young Adult | 2010 |
Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Drug Dosage Calculations; Female; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Male; Vancomycin | 2011 |
A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Humans; Infusions, Intravenous; Plasma; Vancomycin | 2011 |
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Linezolid; Male; Metabolic Clearance Rate; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Vancomycin | 2011 |
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Vancomycin | 2011 |
Initial dosing of vancomycin in critically ill patients.
Topics: Anti-Bacterial Agents; APACHE; Critical Illness; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Sepsis; Vancomycin | 2011 |
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Vancomycin | 2011 |
Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Models, Biological; Multiple Organ Failure; Obesity; Prospective Studies; Renal Insufficiency; Severity of Illness Index; Software; Vancomycin | 2011 |
Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nomograms; Teicoplanin; Vancomycin; Young Adult | 2011 |
Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Body Weight; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Patient Education as Topic; Vancomycin | 2012 |
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story.
Topics: Anti-Bacterial Agents; Body Fluid Compartments; Cardiac Output; Cardiac Surgical Procedures; Critical Illness; Female; Fluid Therapy; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Monitoring, Intraoperative; Pneumonia, Staphylococcal; Sepsis; Thermodilution; Vancomycin | 2011 |
Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; APACHE; Area Under Curve; Cohort Studies; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Kidney; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Prospective Studies; Treatment Failure; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Sepsis; Serum; Vancomycin | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin | 2012 |
Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
Topics: Acetamides; Adult; Aged; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injury Severity Score; Intensive Care Units; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiration, Artificial; Retrospective Studies; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Survival Rate; Trauma Centers; Treatment Outcome; Vancomycin; Wounds and Injuries | 2012 |
The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Malaysia; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2012 |
[Antimicrobial dosing in critically ill patients requiring renal replacement therapy - maximize efficacy and minimize toxicity!].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Prediction of distribution volume of vancomycin in critically ill patients using extravascular lung water and pulmonary vascular permeability indices.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Capillary Permeability; Critical Illness; Extravascular Lung Water; Female; Hemodynamics; Humans; Hydrophobic and Hydrophilic Interactions; Japan; Lung; Male; Middle Aged; Models, Statistical; Monitoring, Physiologic; Pulmonary Edema; Retrospective Studies; Thermodilution; Tissue Distribution; Vancomycin | 2012 |
Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Drug Monitoring; Female; Hemofiltration; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2014 |
Impact of vancomycin minimum inhibitory concentration on mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Confidence Intervals; Critical Illness; Endocarditis; Female; Hospital Mortality; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Respiration, Artificial; Retrospective Studies; Shock; Staphylococcal Infections; Vancomycin | 2012 |
Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Critical Illness; Cross-Over Studies; Female; Hemofiltration; Humans; Male; Middle Aged; Multiple Organ Failure; Prospective Studies; Shock, Septic; Vancomycin | 2002 |
[Enterococcal infections in critically ill patients admitted to ICU].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Prospective Studies; Urinary Tract Infections; Vancomycin | 2003 |
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Vancomycin | 2004 |
Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg.
Topics: Aged; Critical Illness; Dose-Response Relationship, Drug; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Vancomycin | 2006 |
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Creatine; Critical Illness; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Vancomycin | 2006 |
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Empiric antimicrobial therapy in critical illness: results of a surgical infection society survey.
Topics: Anti-Infective Agents; Critical Illness; Fever; General Surgery; Health Care Surveys; Humans; Intensive Care Units; Leukocytosis; Multiple Organ Failure; Practice Patterns, Physicians'; Societies, Medical; Vancomycin | 2007 |
[Comments on the recommendations for antibiotic treatment of gram positive coccal infections in the critical patient].
Topics: Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Health Planning Guidelines; Humans; Methicillin Resistance; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
Topics: Adult; Aged; Critical Illness; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Polymers; Renal Dialysis; Sulfones; Vancomycin | 1995 |
Pharmacokinetics of vancomycin during continuous hemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; France; Half-Life; Hemodiafiltration; Hemodialysis Solutions; Humans; Male; Middle Aged; Prospective Studies; Time Factors; Vancomycin | 1993 |
Changes in vancomycin pharmacokinetics in critically ill infants.
Topics: Anti-Bacterial Agents; Bacterial Infections; Creatinine; Critical Illness; Drug Monitoring; Fluid Therapy; Half-Life; Humans; Infant; Infusions, Intravenous; Metabolic Clearance Rate; Tissue Distribution; Vancomycin | 1995 |
Necessity of a loading dose when using vancomycin in critically ill patients.
Topics: Critical Illness; Dose-Response Relationship, Drug; Humans; Vancomycin | 1992 |